Literature DB >> 7065229

Drug entry into and distribution within brain and cerebrospinal fluid: [14C]urea pharmacokinetics.

S I Rapoport, R Fitzhugh, K D Pettigrew, U Sundaram, K Ohno.   

Abstract

A four-compartment model was derived to analyze drug exchange among cerebral capillary plasma, cerebrospinal fluid (CSF), and the brain extracellular and intracellular (or bound) compartments. Equations that were derived incorporated the factor of cerebral blood flow. They were fit by nonlinear least squares to measured brain, plasma, and CSF (when available) concentrations of [14C]urea in the rat, in response to a step increase in plasma concentration, to intravenous infusion, or to a bolus injection of tracer. Best-fit values for the transfer constants were consistent among the three administrative regimens and agreed with published values, when available. Expressions also were derived and numerically evaluated for the lower limit of the brain extracellular space, for half times of brain [14C]urea uptake, and for the steady-state brain/plasma distribution volume. The model should make it possible to use transfer constants obtained for a given drug from one study (e.g., constant plasma concentration) to predict brain concentrations from measured plasma concentrations in other acute or chronic studies.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7065229     DOI: 10.1152/ajpregu.1982.242.3.R339

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

Review 1.  Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications.

Authors:  S I Rapoport
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

2.  Computation of log BB values for compounds transported through carrier-mediated mechanisms using in vitro permeability data from brain microvessel endothelial cell (BMEC) monolayers.

Authors:  Helen H Usansky; Patrick J Sinko
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

Review 3.  Targeting the brain: rationalizing the novel methods of drug delivery to the central nervous system.

Authors:  Shailendra Joshi; Eugene Ornstein; Jeffrey N Bruce
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

4.  Quantitative in vivo receptor binding III: Tracer kinetic modeling of muscarinic cholinergic receptor binding.

Authors:  K A Frey; R D Hichwa; R L Ehrenkaufer; B W Agranoff
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

5.  Imaging decreased brain docosahexaenoic acid metabolism and signaling in iPLA(2)β (VIA)-deficient mice.

Authors:  Mireille Basselin; Angelo O Rosa; Epolia Ramadan; Yewon Cheon; Lisa Chang; Mei Chen; Deanna Greenstein; Mary Wohltmann; John Turk; Stanley I Rapoport
Journal:  J Lipid Res       Date:  2010-08-04       Impact factor: 5.922

6.  Dietary n-6 polyunsaturated fatty acid deprivation increases docosahexaenoic acid metabolism in rat brain.

Authors:  Miki Igarashi; Hyung-Wook Kim; Lisa Chang; Kaizong Ma; Stanley I Rapoport
Journal:  J Neurochem       Date:  2012-01-23       Impact factor: 5.372

7.  Imaging upregulated brain arachidonic acid metabolism in HIV-1 transgenic rats.

Authors:  Mireille Basselin; Epolia Ramadan; Miki Igarashi; Lisa Chang; Mei Chen; Andrew D Kraft; G Jean Harry; Stanley I Rapoport
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-28       Impact factor: 6.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.